Company to host conference call at 8:00 AM ET
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist...
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total...
Twist Bioscience: Fiscal Q2 Earnings Snapshot
Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March...
Barchart Research What to Expect from TWST Earnings TWST Generated May 1, 2026 Current Price $60.40 EPS Estimate $$-0.54 Consensus Rating Strong Buy Average Move 9.38% Twist Bioscience's Path to Breakeven...
Barchart Research What to Expect from TWST Earnings TWST Generated May 1, 2026 Current Price $60.40 EPS Estimate $$-0.54 Consensus Rating Strong Buy Average Move 9.38% Twist Bioscience's Path to Breakeven...
Barchart Research What to Expect from TWST Earnings TWST Generated May 1, 2026 Current Price $60.40 EPS Estimate $$-0.54 Consensus Rating Strong Buy Average Move 9.38% Twist Bioscience's Path to Breakeven...
Company to host conference call at 8:00 AM ET Investor Day Scheduled for May 21, 2026